Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Health Affairs Scholar

Persistence and geographic availability of Medicare Part D coverage for non-diabetes GLP-1 therapies, 2024-2026

  • Eunhae Shin
  • Alice Chen
Read full textPDFDOICite

Related

  1. Structural Brain Imaging for Newly Diagnosed Cognitive Impairment by Medicare Coverage Type
    Soeren Mattke, Ying Liu, Wei Ye +1
    Journal of the American College of Radiology : JACRPeer-reviewedLicence not statedFull textPsychiatry & mental healthPMC
  2. Geographic and clinical predictors of one-day discharge after radical prostatectomy: a SEER-Medicare cohort study
    J. Hanna, M. R. Shanahan, J. Sykes +3
    medRxivPreprintCC BYFull textGeneral medicinemedRxiv
  3. Arsenic in drinking-water sources in Bangladesh, 2012-13 to 2025: national trends, geographic persistence and implications for well testing
    S. M. A. U. Hoque, M. K. Islam, M. K. Hasan +5
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
  4. Medicare Part D formulary coverage of SGLT2 inhibitors across cardiovascular-kidney-metabolic indications, 2019-2026.
    Vidur Jain, Rozalina G McCoy
    EndocrinePeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCPMC
  5. Trends in the utilization of minimally invasive therapies for overactive bladder among older adults: a national Medicare study
    Adam Crow, Lufan Wang, Abigail Shatkin-Margolis +5
    UrologyPeer-reviewedCC BYFull textGeneral medicinePMC

Cite

BibTeXRIS
BibTeX
@article{shin2026persistence,
  title = {{Persistence and geographic availability of Medicare Part D coverage for non-diabetes GLP-1 therapies, 2024-2026}},
  author = {Eunhae Shin and Alice Chen},
  journal = {Health Affairs Scholar},
  year = {2026},
  month = oct,
  doi = {10.1093/haschl/qxag299},
  url = {https://doi.org/10.1093/haschl/qxag299},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Persistence and geographic availability of Medicare Part D coverage for non-diabetes GLP-1 therapies, 2024-2026
AU  - Eunhae Shin
AU  - Alice Chen
PY  - 2026
DA  - 2026/10/25
JO  - Health Affairs Scholar
DO  - 10.1093/haschl/qxag299
UR  - https://doi.org/10.1093/haschl/qxag299
SN  - 2976-5390
ER  -